Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2006 1
2007 2
2008 5
2009 4
2010 2
2011 7
2012 9
2013 10
2014 10
2015 5
2016 7
2017 13
2018 20
2019 27
2020 42
2021 39
2022 36
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 32358092

214 results

Results by year

Filters applied: . Clear all
Page 1
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.
Donnelly DJ, Smith RA, Morin P, Lipovšek D, Gokemeijer J, Cohen D, Lafont V, Tran T, Cole EL, Wright M, Kim J, Pena A, Kukral D, Dischino DD, Chow P, Gan J, Adelakun O, Wang XT, Cao K, Leung D, Bonacorsi SJ Jr, Hayes W. Donnelly DJ, et al. J Nucl Med. 2018 Mar;59(3):529-535. doi: 10.2967/jnumed.117.199596. Epub 2017 Oct 12. J Nucl Med. 2018. PMID: 29025984 Free article.
In Vivo Imaging of the Programmed Death Ligand 1 by 18F PET.
González Trotter DE, Meng X, McQuade P, Rubins D, Klimas M, Zeng Z, Connolly BM, Miller PJ, O'Malley SS, Lin SA, Getty KL, Fayadat-Dilman L, Liang L, Wahlberg E, Widmark O, Ekblad C, Frejd FY, Hostetler ED, Evelhoch JL. González Trotter DE, et al. J Nucl Med. 2017 Nov;58(11):1852-1857. doi: 10.2967/jnumed.117.191718. Epub 2017 Jun 6. J Nucl Med. 2017. PMID: 28588151 Free article.
In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1.
Rubins DJ, Meng X, McQuade P, Klimas M, Getty K, Lin SA, Connolly BM, O'Malley SS, Haley H, Purcell M, Gantert L, Holahan M, Lindgren J, Eklund P, Ekblad C, Frejd FY, Hostetler ED, González Trotter DE, Evelhoch JL. Rubins DJ, et al. Mol Imaging Biol. 2021 Apr;23(2):241-249. doi: 10.1007/s11307-020-01544-2. Epub 2020 Oct 23. Mol Imaging Biol. 2021. PMID: 33098025
Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer.
Huisman MC, Niemeijer AN, Windhorst AD, Schuit RC, Leung D, Hayes W, Poot A, Bahce I, Radonic T, Oprea-Lager DE, Hoekstra OS, Thunnissen E, Hendrikse NH, Smit EF, de Langen AJ, Boellaard R. Huisman MC, et al. J Nucl Med. 2020 Oct;61(10):1455-1460. doi: 10.2967/jnumed.119.240895. Epub 2020 Feb 14. J Nucl Med. 2020. PMID: 32060213 Free article.
Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide.
Lesniak WG, Mease RC, Chatterjee S, Kumar D, Lisok A, Wharram B, Kalagadda VR, Emens LA, Pomper MG, Nimmagadda S. Lesniak WG, et al. Mol Imaging. 2019 Jan-Dec;18:1536012119852189. doi: 10.1177/1536012119852189. Mol Imaging. 2019. PMID: 31187691 Free PMC article.
214 results